Nanobiotechnology are materials that are composed of particles that are between 1-100 nanometers in size. They are used in many industries, including electronics and medical devices, due to their unique properties that make them useful for specific applications. However, due to the lack of research into their potential risks and hazards, there is a need to regulate the use of Nanobiotechnology. The first step in regulating Nanobiotechnology is to identify and assess their potential hazards. This involves studying their composition, size, shape, and structure. It also involves understanding how they interact with other materials, their environment, and the organisms they come into contact with. Once these hazards have been identified, appropriate safety measures can be taken to minimize any potential risks. The next step is to develop regulations that provide guidance on the safe use of Nanobiotechnology. This includes establishing limits for their release into the environment, as well as providing information about their use and disposal. Regulations should also address how to handle the waste generated from their use, including any hazardous material that may be produced. Finally, it is important to monitor the use of Nanobiotechnology to ensure that regulations are being followed.
Title : 40,000 implants in humans and no failure: The impact of nanomedicine
Thomas J Webster, Hebei University of Technology, China
Title : Cellulose-derived biochar modified with iron oxide and ZnO nanoparticles by a novel one-step pyrolytic method for removal of emerging contaminants from water
Rashad Al Gaashani, Hamad Bin Khalifa University, Qatar
Title : Harnessing the unique properties of engineered nanostructures for sensing
Harry Ruda, University of Toronto, Canada
Title : Circumventing challenges in developing CVD graphene on steels for extraordinary and durable corrosion resistance
Raman Singh, Monash University, Australia
Title : Nano DAP augments productivity, phosphorus use efficiency, and profitability of spring wheat in India
Binaya Kumar Parida, Coromandel International Ltd, India
Title : Lipid nanoparticles formulations: From bench scale to industrial scale
Mohammad A Obeid, RAK Medical and Health Sciences University, United Arab Emirates